refresh
Biogen
Specializing in the treatment of neurological diseases.
Drug Discovery
Clinical Trials
Bioinformatics
Regulatory Affairs
Biomarker Research
Cambridge, Massachusetts
5,001-10,000
1978年成立(第48年)
混合办公
Public
估值
$16.2B
融资总额
$549M
最近融资
Series B
BIIB
$189.9
营收 (2026)
$0
营业利润
官网
LinkedIn
GitHub
X